We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$51.2M
Cap. Flow
-$43M
Cap. Flow %
-4.01%
Top 10 Hldgs %
8.18%
Holding
1,747
New
747
Increased
219
Reduced
207
Closed
574

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.1M
2
AAPL icon
Apple
AAPL
+$8.41M
3
MSI icon
Motorola Solutions
MSI
+$7.68M
4
JD icon
JD.com
JD
+$7.3M
5
ITW icon
Illinois Tool Works
ITW
+$6.58M

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$11.4M
2
KVUE icon
Kenvue
KVUE
+$8.1M
3
RTX icon
RTX Corp
RTX
+$7.61M
4
CSCO icon
Cisco
CSCO
+$6.72M
5
ADBE icon
Adobe
ADBE
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 16.62%
2 Financials 15.83%
3 Consumer Discretionary 13.61%
4 Healthcare 10.98%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AREC icon
1151
American Resources Corp
AREC
$184M
$55.1K 0.01%
+36,983
New +$56.6K
BDTX icon
1152
Black Diamond Therapeutics
BDTX
$100M
$55K 0.01%
+19,569
New +$45.9K
ARC
1153
DELISTED
ARC Document Solutions, Inc.
ARC
$54.9K 0.01%
+16,746
New +$49.1K
FREE
1154
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$54.7K 0.01%
+16,029
New +$54.1K
PHX
1155
DELISTED
PHX Minerals
PHX
$53.4K 0.01%
+16,590
New +$57K
SCLX icon
1156
Scilex Holding
SCLX
$49.2M
$52.9K ﹤0.01%
+741
New +$38.4K
MAMA icon
1157
Mama's Creations
MAMA
$828M
$52.7K ﹤0.01%
+10,725
New +$42.3K
CSTE icon
1158
Caesarstone
CSTE
$72.6M
$52.4K ﹤0.01%
+14,022
New +$56.6K
ABEO icon
1159
Abeona Therapeutics
ABEO
$340M
$52.2K ﹤0.01%
+10,414
New +$45.8K
ARQT icon
1160
Arcutis Biotherapeutics
ARQT
$3.53B
$51K ﹤0.01%
+15,804
New +$43K
CAPR icon
1161
Capricor Therapeutics
CAPR
$338M
$50.2K ﹤0.01%
+10,263
New +$33.4K
SRT
1162
DELISTED
Startek Inc.
SRT
$48.4K ﹤0.01%
+10,976
New +$46.3K
AQST icon
1163
Aquestive Therapeutics
AQST
$460M
$47.6K ﹤0.01%
+23,572
New +$41.7K
ETON icon
1164
Eton Pharmaceutcials
ETON
$1.25B
$46.8K ﹤0.01%
+10,688
New +$42.8K
LL
1165
DELISTED
LL Flooring Holdings, Inc.
LL
$46.6K ﹤0.01%
+11,940
New +$39.8K
EGY icon
1166
Vaalco Energy
EGY
$539M
$46.1K ﹤0.01%
10,264
-13,013
-56% -$57.2K
CVM icon
1167
CEL-SCI Corp
CVM
$21M
$45.3K ﹤0.01%
+555
New +$34.6K
KNTE
1168
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$43.6K ﹤0.01%
+18,410
New +$32.6K
OPRT icon
1169
Oportun Financial
OPRT
$270M
$41.7K ﹤0.01%
+10,658
New +$45.5K
APLT
1170
DELISTED
Applied Therapeutics
APLT
$37K ﹤0.01%
+11,048
New +$27.5K
TCS
1171
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$35.5K ﹤0.01%
+1,038
New +$31.4K
EXK
1172
Endeavour Silver
EXK
$2.28B
$30.4K ﹤0.01%
+15,456
New +$33.6K
GERN icon
1173
Geron
GERN
$937M
$24.8K ﹤0.01%
+11,777
New +$22.9K
A icon
1174
Agilent Technologies
A
$39.4B
– –
-15,502
Closed -$1.73M
ABCB icon
1175
Ameris Bancorp
ABCB
$5.85B
– –
-9,008
Closed -$346K
45 46
47
48 49

Similar funds

HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.02B AUM 21.87% 1-Year Est. Return

Y-Intercept (HK)'s Q4 2023 Portfolio in Review

As of Q4 2023, Y-Intercept (HK) held 1,747 positions worth $1.07B, up 5% from $1.02B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Y-Intercept (HK) withdrew a net $43M in Q4 2023, closing 574 positions and reducing 207 holdings. Its most notable exit was Blackstone, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Y-Intercept (HK) opened a new position in Merck worth $12.7M.

  • Y-Intercept (HK)'s largest Q4 2023 buy was Merck: 116,714 shares worth $12.7M.
  • Y-Intercept (HK) added most to Apple in Q4 2023, an estimated $8.41M increase.
  • Y-Intercept (HK)'s biggest Q4 2023 reduction was Kenvue, cutting an estimated $8.1M.
  • Y-Intercept (HK) fully exited Blackstone in Q4 2023, selling an estimated $11.4M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $1.07B portfolio in Q4 2023.
  • Y-Intercept (HK) opened 747 new positions and closed 574 in Q4 2023.
  • Y-Intercept (HK)'s portfolio value rose 5% quarter-over-quarter to $1.07B.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.